This article is more than 5 years old. Information may no longer be current.

Maculogix appoints McPhee as new CEO

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Maculogix announced that its board of directors has appointed William McPhee as CEO of the company, according to a press release.

McPhee has 35 years of experience in strategy and operations consulting, fundraising, transactions and venture capital. He served as CEO of eSight Corp. and is a member of Boston Harbor Angels and Mass Medical Angels.

“Bill McPhee has a proven track record of building businesses and a true passion for vision-related technology. As a long-term investor in Maculogix, we are excited to support Bill as he builds on the success the company has achieved under the leadership of John Edwards,” Tracy Saxton, PhD, investment director of Roche Venture Fund, the lead investor in Maculogix, said in the release.